Jessica Lin

Papers

1

Total Citations

63

H-Index

1

About

Dr. Jessica Lin is a leading figure in nanomedicine and drug delivery, whose work has significantly advanced the development of lipid nanoparticle (LNP) technologies. Her research focuses on the intersection of materials science and molecular biology, particularly in creating scalable, high-throughput methods for formulating and characterizing nucleic acid therapeutics. Dr. Lin’s most cited work, "Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles" (2021, 63 citations), exemplifies her core contribution: engineering robust, automated platforms that streamline the production and quality control of LNPs. This innovation is pivotal for translating gene-silencing oligonucleotides and mRNA-based therapies from lab bench to clinical application, addressing a critical bottleneck in the field. By enabling rapid, reproducible screening of LNP formulations, her research accelerates the discovery of safer and more effective delivery systems for genetic medicines. Dr. Lin’s work has been widely recognized for its practical impact on pharmaceutical development, making her a key voice in the next generation of nanocarrier design. Her ongoing efforts continue to shape how researchers and industry approach the manufacturing and characterization of complex nanoparticle therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
63
Total Citations
63
Avg Citations/Paper
🏆 Most Cited Paper
Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles
63 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago